Plant Advanced Technologies SA Market Cap ($4.92 Million)
Market Cap & Net Worth: Plant Advanced Technologies SA (ALPAT)
Plant Advanced Technologies SA market cap. Plant Advanced Technologies SA (PA:ALPAT) has a market capitalization of $4.92 Million (€4.21 Million) as of November 8, 2026. Listed on the PA stock exchange, this France-based company holds position #28531 globally and #510 in its home market, demonstrating a 6.95% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Plant Advanced Technologies SA's stock price €4.00 by its total outstanding shares 1139248 (1.14 Million). Also see Plant Advanced Technologies SA (ALPAT) cash conversion ratio for how efficiently the company converts equity into cash flow.
Plant Advanced Technologies SA Market Cap History (2015–2026)
Plant Advanced Technologies SA market cap history from 2015 to 2026. Data shows change from $34.43 Million to $5.33 Million (-15.77% CAGR). Check ALPAT share price today for real-time trading data and today's change.
Plant Advanced Technologies SA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Plant Advanced Technologies SA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore ALPAT year-over-year net asset growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
9.60x
Plant Advanced Technologies SA's market cap is 9.60 times its annual revenue
Latest Price to Earnings (P/E) Ratio
19.18x
Plant Advanced Technologies SA's market cap is 19.18 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $24.92 Million | $1.58K | -$1.13K | 15800.87x | N/A |
| 2017 | $32.74 Million | $1.46K | -$674.79 | 22386.72x | N/A |
| 2018 | $21.44 Million | $1.87K | $864.51 | 11452.04x | 24804.34x |
| 2019 | $26.37 Million | $1.17 Million | -$541.23K | 22.49x | N/A |
| 2020 | $27.70 Million | $1.72 Million | -$543.00K | 16.12x | N/A |
| 2021 | $24.77 Million | $2.31 Million | -$1.13 Million | 10.75x | N/A |
| 2022 | $17.71 Million | $2.34 Million | -$849.00K | 7.57x | N/A |
| 2023 | $11.25 Million | $1.68 Million | $79.17K | 6.69x | 142.16x |
| 2024 | $15.85 Million | $1.93 Million | $935.13K | 8.22x | 16.95x |
| 2025 | $10.92 Million | $1.14 Million | $569.40K | 9.60x | 19.18x |
Competitor Companies of ALPAT by Market Capitalization
Companies near Plant Advanced Technologies SA in the global market cap rankings as of November 8, 2026. Also see Plant Advanced Technologies SA (ALPAT) total assets for a full breakdown of the balance sheet.
Key companies related to Plant Advanced Technologies SA by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #177 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #363 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #403 globally with a market cap of $69.36 Billion USD ( AU$98.02 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #494 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #177 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $547.09 |
| #363 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $904.35 |
| #403 | CSL Ltd | AU:CSL | $69.36 Billion | AU$202.04 |
| #494 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $254.19 |
Market Capitalization of Plant Advanced Technologies SA (2015–2026)
Market capitalization of Plant Advanced Technologies SA from 2015 to today. Between 2015 and today, Plant Advanced Technologies SA's market cap moved from $34.43 Million to $ 5.33 Million, with a yearly change of -15.77%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €5.33 Million | -51.22% |
| 2025 | €10.92 Million | -31.09% |
| 2024 | €15.85 Million | +40.83% |
| 2023 | €11.25 Million | -36.47% |
| 2022 | €17.71 Million | -28.49% |
| 2021 | €24.77 Million | -10.58% |
| 2020 | €27.70 Million | +5.05% |
| 2019 | €26.37 Million | +22.98% |
| 2018 | €21.44 Million | -34.50% |
| 2017 | €32.74 Million | +31.37% |
| 2016 | €24.92 Million | -27.62% |
| 2015 | €34.43 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 8th, 2026 the market cap of Plant Advanced Technologies SA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $4.92 Million USD |
| MoneyControl | $4.92 Million USD |
| MarketWatch | $4.92 Million USD |
| marketcap.company | $4.92 Million USD |
| Reuters | $4.92 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Plant Advanced Technologies SA
Plant Advanced Technologies SA, a plant biotechnology company, produces and sells actives for cosmetic, pharmaceutical, and agrochemical markets in France. Its technologies include Process PAT Exudactive a sustainable sourcing solution to produce your exclusive, personalized Exudactive; and PAT Target Binding, which finds the ligands that bind to the protein targets of interest, such as enzymes. … Read more